ARUP's Laboratory Test Directory
| 0080281: NMP22® |
| Test Mnemonic: NMP22 | |
|
Methodology: Enzyme Immunoassay
Performed: Mon, Thu Reported: 1-6 days |
| Specimen Required: | |
|
Collect: Single void of urine between midnight and noon. Immediately following collection, add urine to NMP22® Urine Stabilizer Vial. Urine stabilization kit must be ordered through ARUP Client Services (ARUP Supply #12594).
Transport: 5 mL stabilized urine, frozen. Stabilized specimen should be blue/green in color. Unacceptable Conditions: Nonstabilized urine. Stability: Ambient: 48 hours; Refrigerated: 3 days; Frozen: 1 month |
|
| Reference Interval: |
| 0.0-10.0 U/mL |
| Interpretive Data: | |
|
The NMP22® assay is intended as an aid in the management of patients with transitional cell carcinoma of the urinary tract (TCC/UT). It is used after surgical treatment to identify patients with residual or rapidly recurring TCC/UT. Values obtained with different assay methods should not be used interchangeably. ARUP uses the Matritech NMP22® Test Kit which is an enzyme immunoassay (EIA) method. |
| CPT Code(s): | |
| 86316 |